PMID- 24130917 OWN - NLM STAT- MEDLINE DCOM- 20140505 LR - 20211021 IS - 1935-2735 (Electronic) IS - 1935-2727 (Print) IS - 1935-2727 (Linking) VI - 7 IP - 10 DP - 2013 TI - Identification of conserved and HLA promiscuous DENV3 T-cell epitopes. PG - e2497 LID - 10.1371/journal.pntd.0002497 [doi] LID - e2497 AB - Anti-dengue T-cell responses have been implicated in both protection and immunopathology. However, most of the T-cell studies for dengue include few epitopes, with limited knowledge of their inter-serotype variation and the breadth of their human leukocyte antigen (HLA) affinity. In order to expand our knowledge of HLA-restricted dengue epitopes, we screened T-cell responses against 477 overlapping peptides derived from structural and non-structural proteins of the dengue virus serotype 3 (DENV3) by use of HLA class I and II transgenic mice (TgM): A2, A24, B7, DR2, DR3 and DR4. TgM were inoculated with peptides pools and the T-cell immunogenic peptides were identified by ELISPOT. Nine HLA class I and 97 HLA class II novel DENV3 epitopes were identified based on immunogenicity in TgM and their HLA affinity was further confirmed by binding assays analysis. A subset of these epitopes activated memory T-cells from DENV3 immune volunteers and was also capable of priming naive T-cells, ex vivo, from dengue IgG negative individuals. Analysis of inter- and intra-serotype variation of such an epitope (A02-restricted) allowed us to identify altered peptide ligands not only in DENV3 but also in other DENV serotypes. These studies also characterized the HLA promiscuity of 23 HLA class II epitopes bearing highly conserved sequences, six of which could bind to more than 10 different HLA molecules representing a large percentage of the global population. These epitope data are invaluable to investigate the role of T-cells in dengue immunity/pathogenesis and vaccine design. FAU - Nascimento, Eduardo J M AU - Nascimento EJ AD - Department of Infectious Disease and Microbiology, University of Pittsburgh, Pittsburgh, Pennsylvania, United States of America ; Center for Vaccine Research, University of Pittsburgh, Pittsburgh, Pennsylvania, United States of America. FAU - Mailliard, Robbie B AU - Mailliard RB FAU - Khan, Asif M AU - Khan AM FAU - Sidney, John AU - Sidney J FAU - Sette, Alessandro AU - Sette A FAU - Guzman, Nicole AU - Guzman N FAU - Paulaitis, Michael AU - Paulaitis M FAU - de Melo, Andrea Barbosa AU - de Melo AB FAU - Cordeiro, Marli T AU - Cordeiro MT FAU - Gil, Laura V G AU - Gil LV FAU - Lemonnier, Francoir AU - Lemonnier F FAU - Rinaldo, Charles AU - Rinaldo C FAU - August, J Thomas AU - August JT FAU - Marques, Ernesto T A Jr AU - Marques ET Jr LA - eng GR - HHSN272200900042C/AI/NIAID NIH HHS/United States GR - U19 AI056541/AI/NIAID NIH HHS/United States GR - U19 AI5654/AI/NIAID NIH HHS/United States PT - Journal Article PT - Research Support, N.I.H., Extramural DEP - 20131010 PL - United States TA - PLoS Negl Trop Dis JT - PLoS neglected tropical diseases JID - 101291488 RN - 0 (Antigens, Viral) RN - 0 (Epitopes, T-Lymphocyte) RN - 0 (La protein, human) RN - 0 (Phosphoproteins) SB - IM MH - Adolescent MH - Adult MH - Animals MH - Antigens, Viral/*immunology MH - Child MH - Dengue Virus/*immunology MH - Enzyme-Linked Immunospot Assay MH - Epitope Mapping MH - Epitopes, T-Lymphocyte/*immunology MH - Female MH - Healthy Volunteers MH - Humans MH - Male MH - Mice MH - Mice, Transgenic MH - Phosphoproteins/*immunology/*metabolism MH - Protein Binding PMC - PMC3794980 COIS- The authors have declared that no competing interests exist. EDAT- 2013/10/17 06:00 MHDA- 2014/05/06 06:00 PMCR- 2013/10/10 CRDT- 2013/10/17 06:00 PHST- 2013/02/21 00:00 [received] PHST- 2013/09/09 00:00 [accepted] PHST- 2013/10/17 06:00 [entrez] PHST- 2013/10/17 06:00 [pubmed] PHST- 2014/05/06 06:00 [medline] PHST- 2013/10/10 00:00 [pmc-release] AID - PNTD-D-13-00285 [pii] AID - 10.1371/journal.pntd.0002497 [doi] PST - epublish SO - PLoS Negl Trop Dis. 2013 Oct 10;7(10):e2497. doi: 10.1371/journal.pntd.0002497. eCollection 2013.